Cargando…

Salvage High-Dose-Rate Interventional Radiotherapy (Brachytherapy) Combined with Surgery for Regionally Relapsed Head and Neck Cancers

SIMPLE SUMMARY: Many head and neck cancer patients suffer from recurrence of the tumor after previous treatment. The initial treatment usually entails operation, radiation treatment, chemotherapy, or combinations of these treatments. For those patients who have no distant metastases, there are limit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Soror, Tamer, Paul, Justina, Melchert, Corinna, Idel, Christian, Rades, Dirk, Bruchhage, Karl-Ludwig, Kovács, György, Leichtle, Anke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526533/ https://www.ncbi.nlm.nih.gov/pubmed/37760518 http://dx.doi.org/10.3390/cancers15184549

Ejemplares similares

Salvage high-dose-rate interventional radiotherapy (brachytherapy) for locally relapsed prostate cancer after radical prostatectomy and subsequent external irradiation
por: Soror, Tamer, et al.
Publicado: (2023)

Salvage Perioperative Interstitial High-Dose-Rate Interventional Radiotherapy (Brachytherapy) for Local Recurrences of the Chest Wall Following Mastectomy and Previous External Irradiation
por: Soror, Tamer, et al.
Publicado: (2023)

Quality assurance during interstitial brachytherapy: in vivo dosimetry using MOSFET dosimeters
por: Melchert, Corinna, et al.
Publicado: (2018)

Chemoradiation with Cisplatin vs. Carboplatin for Squamous Cell Carcinoma of the Head and Neck (SCCHN)
por: Rades, Dirk, et al.
Publicado: (2023)

A New Prognostic Instrument for Predicting the Probability of Completion of Cisplatin during Chemoradiation for Head and Neck Cancer
por: Rades, Dirk, et al.
Publicado: (2023)

First Results of Concurrent Chemoradiation with Two Courses of 5 × 25 mg/m(2) Cisplatin for Locally Advanced Head and Neck Cancer
por: Zwaan, Inga, et al.
Publicado: (2023)

Biological Planning of Radiation Dose Based on In Vivo Dosimetry for Postoperative Vaginal-Cuff HDR Interventional Radiotherapy (Brachytherapy)
por: Soror, Tamer, et al.
Publicado: (2021)

Smoking-, Alcohol-, and Age-Related Alterations of Blood Monocyte Subsets and Circulating CD4/CD8 T Cells in Head and Neck Cancer
por: Idel, Christian, et al.
Publicado: (2022)

Spatial Distribution of Immune Cells in Head and Neck Squamous Cell Carcinomas
por: Idel, Christian, et al.
Publicado: (2021)

External beam boost versus interstitial high-dose-rate brachytherapy boost in the adjuvant radiotherapy following breast-conserving therapy in early-stage breast cancer: a dosimetric comparison
por: Terheyden, Martje Marie, et al.
Publicado: (2016)

Quality Assurance in Modern Gynecological HDR-Brachytherapy (Interventional Radiotherapy): Clinical Considerations and Comments
por: Soror, Tamer, et al.
Publicado: (2021)

TRIM21 Expression as a Prognostic Biomarker for Progression-Free Survival in HNSCC
por: von Bernuth, Amelie, et al.
Publicado: (2023)

ENT COBRA (Consortium for Brachytherapy Data Analysis): interdisciplinary standardized data collection system for head and neck patients treated with interventional radiotherapy (brachytherapy)
por: Tagliaferri, Luca, et al.
Publicado: (2016)

Modern head and neck brachytherapy: from radium towards intensity modulated interventional brachytherapy
por: Kovács, György
Publicado: (2014)

Performance of Different Diagnostic PD-L1 Clones in Head and Neck Squamous Cell Carcinoma
por: Ribbat-Idel, Julika, et al.
Publicado: (2021)

Increased Abundances of CD16(+) Non-Classical Monocytes Accompany with Elevated Monocytic PD-L1 and CD4(+) T Cell Disturbances in Oropharyngeal Cancer
por: Idel, Christian, et al.
Publicado: (2022)

The role of salvage brachytherapy for local relapse after external beam radiotherapy for prostate cancer
por: Tisseverasinghe, Steven A., et al.
Publicado: (2018)

CDK7 Predicts Worse Outcome in Head and Neck Squamous-Cell Cancer
por: Jagomast, Tobias, et al.
Publicado: (2022)

Stereotactic radiotherapy in neovascular age-related macular degeneration: Real-life efficacy and morphological evaluation of the outer retina-choroid complex
por: Ranjbar, Mahdy, et al.
Publicado: (2016)

ENT COBRA ONTOLOGY: the covariates classification system proposed by the Head & Neck and Skin GEC-ESTRO Working Group for interdisciplinary standardized data collection in head and neck patient cohorts treated with interventional radiotherapy (brachytherapy)
por: Tagliaferri, Luca, et al.
Publicado: (2018)

Radiotherapy related skin toxicity (RAREST-01): Mepitel® film versus standard care in patients with locally advanced head-and-neck cancer
por: Narvaez, Carlos, et al.
Publicado: (2018)

Immunologic “Cold” Squamous Cell Carcinomas of the Head and Neck Are Associated With an Unfavorable Prognosis
por: Ribbat-Idel, Julika, et al.
Publicado: (2021)

Modes of Action of 1,8-Cineol in Infections and Inflammation
por: Pries, Ralph, et al.
Publicado: (2023)

CDK19 as a Potential HPV-Independent Biomarker for Recurrent Disease in HNSCC
por: Paulsen, Finn-Ole, et al.
Publicado: (2020)

NR2F6 as a Prognostic Biomarker in HNSCC
por: Klapper, Luise, et al.
Publicado: (2020)

TRIM24 Expression as an Independent Biomarker for Prognosis and Tumor Recurrence in HNSCC
por: Klapper, Luise, et al.
Publicado: (2022)

The role of salvage surgery with interstitial brachytherapy for the Management of Regionally Recurrent Head and Neck Cancers
por: Khan, Nayel, et al.
Publicado: (2019)

Impact of a mobile application (reminder app) on acute toxicity during radiotherapy of head-and-neck cancer – results of a randomized phase III trial (RAREST-02)
por: Rades, Dirk, et al.
Publicado: (2022)

Einfluss von Richtmikrofonie auf die Höranstrengung bei Mittelohrimplantatträgern
por: Hollfelder, Daniela, et al.
Publicado: (2022)

Salvage brachytherapy for local recurrences of prostate cancer treated previously with radiotherapy
por: Gawkowska-Suwinska, Marzena, et al.
Publicado: (2010)

Plasma‑derived CD16 exosomes and peripheral blood monocytes as correlating biomarkers in head and neck cancer
por: Theodoraki, Marie-Nicole, et al.
Publicado: (2023)

Salvage for cervical recurrences of head and neck cancer with dissection and interstitial high dose rate brachytherapy
por: Pellizzon, Antonio Cassio Assis, et al.
Publicado: (2006)

High-dose-rate interstitial brachytherapy in recurrent head and neck cancer: an effective salvage option
por: Bhalavat, Rajendra, et al.
Publicado: (2018)

Salvage brachytherapy for locally recurrent prostate cancer after external beam radiotherapy
por: Yamada, Yasuhiro, et al.
Publicado: (2015)

Salvage Brachytherapy for Biochemically Recurrent Prostate Cancer following Primary Brachytherapy
por: Lacy, John M., et al.
Publicado: (2016)

Age Is Not a Limiting Factor in Interventional Radiotherapy (Brachytherapy) for Patients with Localized Cancer
por: Lancellotta, Valentina, et al.
Publicado: (2018)

Neither high-dose nor low-dose brachytherapy increases flap morbidity in salvage treatment of recurrent head and neck cancer
por: Henderson, Peter W., et al.
Publicado: (2016)

Nonmetastatic castration‐resistant prostate cancer treated with salvage focal brachytherapy after external beam radiotherapy
por: Yoshida, Soichiro, et al.
Publicado: (2021)

Immunomodulation as a Protective Strategy in Chronic Otitis Media
por: Leichtle, Anke, et al.
Publicado: (2022)

Salvage surgery in head and neck cancer
por: van Weert, Stijn, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ui8ii7a6lqpuujpa0fgraqcbpm